Investor Outlook: Bausch + Lomb Corporation (BLCO) Eyes 12% Upside Potential Amid Steady Growth
Bausch + Lomb Corporation (BLCO), a healthcare company specializing in medical instruments, shows a stable performance with an intriguing opportunity for investors. Despite negative EPS and ROC, the company demonstrates strong revenue growth and free cash flow, indicative of strategic reinvestment for long-term growth. …